QPPV.COM KNOWLEDGE ASSESSMENT

Knowledge Assessment: How RMS and CMS Roles Work Together in MRP and DCP

Test your understanding of the concepts covered by How RMS and CMS Roles Work Together in MRP and DCP.

Question 1 of 10Pass mark: 80%

Question 1 of 10 Which record would best support later reconstruction of an important regulatory decision?

Only the final authorisation date and the name of the RMS. Only the final agreed product information. The issue raised, supporting evidence, response, conclusion and effect on the regulatory position. A list of all emails without identifying the scientific issue discussed.

Question 2 of 10 Why is the RMS assessment important to the functioning of an MRP or DCP?

It provides a common scientific framework for CMS review and reduces unnecessary duplication. It replaces the need for CMSs to consider the scientific conclusions. It creates a single EU-wide marketing authorisation automatically. It limits the applicant to communicating only with the CMSs.

Question 3 of 10 Which approach would best help a company determine whether its current safety information remains aligned across participating Member States?

Review only the historical RMS assessment. Compare the current national authorisations and product information with the coordinated regulatory history and subsequent procedures. Assume alignment because the product originally completed a DCP. Ask only the original RMS to confirm the legal status in every country.

Question 4 of 10 A competent authority acts as RMS for one product procedure and as CMS for another. What is the most appropriate interpretation?

The authority has changed its permanent regulatory status. The authority is acting inconsistently with the EU regulatory system. RMS and CMS designations are procedural roles that may differ across products and procedures. An authority may act as RMS only once and must thereafter remain a CMS.

Question 5 of 10 A regulatory professional reviewing a legacy file finds no record of how a major CMS safety concern was resolved. What is the principal deficiency?

The absence of a national authorisation automatically invalidates the product. The file lacks traceability between the concern, evidence, responses and final regulatory conclusion. The RMS should have been replaced by the applicant. CMS concerns are not required to be documented if the procedure concluded.

Question 6 of 10 Which statement best explains why coordinated assessment does not create a single EU-wide marketing authorisation in an MRP or DCP?

The RMS assessment has no legal relevance outside the RMS Member State. The procedures combine common scientific work with continuing national authorisation responsibilities. CMSs are prohibited from granting or maintaining national authorisations. Only the European Commission can issue authorisations after every MRP or DCP.

Question 7 of 10 Which statement most accurately describes the pharmacovigilance implication of an MRP or DCP history?

The QPPV automatically becomes the owner of the original MRP or DCP. The RMS permanently controls all future safety actions in every participating country. The pharmacovigilance system should identify the regulatory history, authorised safety information and responsibilities relevant to subsequent action. Pharmacovigilance teams do not need to know the RMS or CMS composition after authorisation.

Question 8 of 10 Why can a change to a warning in product information require more than editorial review?

All product-information changes are legally irrelevant once the dossier is submitted. Wording may reflect a substantive conclusion about evidence, safety or risk minimisation. Only the applicant can determine whether wording is scientific. CMSs are not permitted to review product information.

Question 9 of 10 Which description best captures the relationship between the RMS and CMSs in an MRP or DCP?

The RMS is hierarchically superior and directs the CMSs as subordinate regulators. The RMS and CMSs are complementary national authorities cooperating within a common procedure. The CMSs independently reassess the entire dossier and the RMS only records their conclusions. The RMS acts as an EU-wide marketing-authorisation authority for all participating Member States.

Question 10 of 10 What balance is the RMS/CMS model designed to achieve?

Complete national independence with no reliance between authorities. A single centralised authority replacing all national competent authorities. Efficiency through shared assessment while retaining national regulatory responsibility. Administrative uniformity without scientific discussion.

Knowledge Assessment: How RMS and CMS Roles Work Together in MRP and DCP

Cookie Settings